PI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-4144
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy

Clinical Cancer Drugs
Cancer ResearchToxicologyOncologyPharmaceuticsPharmacology
2016English

Status of PI3K/Akt/mTOR Pathway Inhibitors in Lymphoma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2014English

Targeting the PI3K/Akt/mTOR Signalling Pathway in Cystic Fibrosis

Scientific Reports
Multidisciplinary
2017English

Targeting the PI3K/AKT/MTOR Pathway in KSHV-associated Cancers

Infectious Agents and Cancer
Cancer ResearchEpidemiologyOncologyInfectious Diseases
2009English

miR-221/222 Promote Malignant Progression of Glioma Through Activation of the Akt Pathway

International Journal of Oncology
Cancer ResearchOncology
2010English

PI3K/PTEN/Akt/mTOR Pathway Aberrations and Co-Incidence of Hormone Receptors and HER2 in 19,784 Diverse Solid Tumors.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2015English

Angelica Sinensis Promotes Myotube Hypertrophy Through the PI3K/Akt/mTOR Pathway

BMC Complementary and Alternative Medicine
MedicineAlternative MedicineComplementary
2014English

Acetylshikonin Inhibits Colorectal Cancer Growth via PI3K/Akt/mTOR Signaling Pathway

Chinese Medicine
2018English

Author Correction: Alpha-Fetoprotein Inhibits Autophagy to Promote Malignant Behaviour in Hepatocellular Carcinoma Cells by Activating PI3K/AKT/mTOR Signalling

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy